Advertisement
Canada markets open in 7 hours 7 minutes

  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     

  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • CAD/USD

    0.7278
    +0.0014 (+0.20%)
     

  • CRUDE OIL

    82.77
    +0.08 (+0.10%)
     

  • Bitcoin CAD

    83,957.52
    -3,827.75 (-4.36%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,392.80
    +4.40 (+0.18%)
     

  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     

  • 10-Yr Bond

    4.5850
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,763.75
    +105.25 (+0.60%)
     

  • VOLATILITY

    18.21
    -0.19 (-1.03%)
     

  • FTSE

    7,847.99
    +27.63 (+0.35%)
     

  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     

  • CAD/EUR

    0.6804
    +0.0002 (+0.03%)
     

Global Enzyme Replacement Therapy Market to Reach $15.16 Billion By 2030: Allied Market Research

Allied Market Research
·4 min read

Increase in the prevalence of rare diseases, availability of wide range of products, and supportive government initiatives for rare diseases drive the growth of the global enzyme replacement therapy market. The Covid-19 pandemic led to decreased public mobility and affected the diagnostic industries. Non-urgent diagnostic procedures and scheduled enzyme replacement therapies were postponed with increase in burden on the healthcare systems to treat Covid-19 infected patients.

Portland, OR, Oct. 18, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Enzyme Replacement Therapy Market generated $7.78 billion in 2020, and is expected to reach $15.16 billion by 2030, witnessing a CAGR of 8.3% from 2021 to 2030. The report provides a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/11314

Increase in the prevalence of rare diseases, availability of wide range of products, and supportive government initiatives for rare diseases drive the growth of the global enzyme replacement therapy market. However, high cost of the treatment hinders the market growth. On the other hand, new developments in therapies present new opportunities in the coming years.

ADVERTISEMENT

Covid-19 Scenario:

  • The Covid-19 pandemic led to decreased public mobility and affected the diagnostic industries. Non-urgent diagnostic procedures and therapies were postponed with increase in burden on the healthcare systems to treat Covid-19 infected patients.

  • Scheduled enzyme replacement therapy processes were disrupted and postponed during the Covid-19 pandemic. However, the therapies were carried out in urgent cases only.

The report offers detailed segmentation of the global enzyme replacement therapy market based on product, disease, end user, and region.

Based on disease, the mucopolysaccharidosis segment contributed to the highest share in 2020, accounting for nearly one-fourth of the total share, and is estimated to maintain its lead position during the forecast period. Moreover, this segment is expected to portray the fastest CAGR of 10.6% from 2021 to 2030. The report also analyzes the segments including Gaucher disease, Fabry disease, Pompe disease, exocrine pancreatic insufficiency (EPI), and others.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/11314

Based on end user, the hospitals segment accounted for the highest share in 2020, contributing to more than four-fifths of the global enzyme replacement therapy market, and is expected to continue its dominant share in terms of revenue during the forecast period. Moreover, this segment is estimated to witness the highest CAGR of 8.5% from 2021 to 2030. The research also analyzes the infusion centers & home healthcare setting segment.

Based on region, North America held the highest share in 2020, accounting for more than two-fifths of the total share, and is estimated to maintain its leadership status by 2030. However, Asia-Pacific is expected to register the largest CAGR of 21.7% during the forecast period.

Leading players of the global enzyme replacement therapy market analyzed in the research include Abbvie Inc., Biomarin Pharmaceutical Inc., AstraZeneca Plc, Digestive Care, Inc., Chiesi Farmaceutici S.P.A, Nestle Health Science, Leadiant Biosciences, Inc., Sanofi, Pfizer, Inc., and Takeda Pharmaceuticals.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Surgical Robots Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Transcatheter Aortic Valve Implantation (TAVI) Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Cytogenetics Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Diagnostic Imaging Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Stents Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Prefilled Syringes Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Photomedicine Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

HIV Drug Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

France IVD Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com/reports-store/life-sciences Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/